Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls - A longitudinal cohort study

被引:76
作者
AnderssonEllstrom, A
Dillner, J
Hagmar, B
Schiller, J
Sapp, M
Forssman, L
Milsom, I
机构
[1] CTR PUBL HLTH RES, KARLSTAD, SWEDEN
[2] DIST HLTH CTR GRIPEN, KARLSTAD, SWEDEN
[3] KAROLINSKA INST, CTR MICROBIOL & TUMOR BIOL, STOCKHOLM, SWEDEN
[4] OSLO UNIV HOSP, DEPT CLIN CYTOL, OSLO, NORWAY
[5] NIH, CELLULAR ONCOL LAB, BETHESDA, MD 20892 USA
[6] UNIV MAINZ, DEPT MED MICROBIOL, W-6500 MAINZ, GERMANY
[7] UNIV HOSP OSTRA SJUKHUSET, DEPT OBSTET & GYNECOL, GOTHENBURG, SWEDEN
关键词
D O I
10.1097/00007435-199605000-00013
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
Objectives: To study the importance of sexual activity and early coitus debut on the risk for acquiring infection with human papillomavirus (HPV) type 16 or 33. Study Design: Ninety-eight healthy adolescent girls were followed up with consecutive interviews and donations of serum and cervical brush samples during 2 years. Results: Fourteen percent of sexually experienced girls had serum immunoglobulin G to HPV16 and/or HPV33 capsids, and 14% also had cervical HPV16 or HPV33 DNA. Seropositivity for HPV correlated with detection of cervical HPV DNA. None of the 36 girls without coital experience was seropositive or harbored cervical HPV DNA, Seropositivity for HPV was correlated strongly with the number of sexual partners: Odds ratio for >1 sexual partner was 16.3 (P < 0.001), and for early coitus debut (younger than 17 years of age), it was 14.3 (P < 0.002). Conclusions: Both HPV serology and HPV DNA testing indicated that the number of sexual partners and earliness of coitus debut determined the risk for acquiring HPV infection and that nonsexually transmitted infections are rare or nonexistent among adolescent girls.
引用
收藏
页码:234 / 238
页数:5
相关论文
共 32 条
[1]
ANDERSSONELLSTR.A, 1996, IN PRESS INT J STD A
[2]
NO SEROLOGICAL EVIDENCE FOR NONSEXUAL SPREAD OF HPV16 [J].
ANDERSSONELLSTROM, A ;
DILLNER, J ;
HAGMAR, B ;
SCHILLER, J ;
FORSSMAN, L .
LANCET, 1994, 344 (8934) :1435-1435
[3]
GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN FEMALE UNIVERSITY-STUDENTS AS DETERMINED BY A PCR-BASED METHOD [J].
BAUER, HM ;
TING, Y ;
GREER, CE ;
CHAMBERS, JC ;
TASHIRO, CJ ;
CHIMERA, J ;
REINGOLD, A ;
MANOS, MM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (04) :472-477
[4]
BRINTON LA, 1987, J NATL CANCER I, V79, P23
[5]
ERLICH HA, 1989, DNA TYPING EVOLUTION, P193
[6]
HUMAN PAPILLOMAVIRUS INFECTION IS TRANSIENT IN YOUNG-WOMEN - A POPULATION-BASED COHORT STUDY [J].
EVANDER, M ;
EDLUND, K ;
GUSTAFSSON, A ;
JONSSON, M ;
KARLSSON, R ;
RYLANDER, E ;
WADELL, G .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :1026-1030
[7]
THE ABSENCE OF GENITAL HUMAN PAPILLOMAVIRUS DNA IN VIRGINAL WOMEN [J].
FAIRLEY, CK ;
CHEN, SJ ;
TABRIZI, SN ;
LEETON, K ;
QUINN, MA ;
GARLAND, SM .
INTERNATIONAL JOURNAL OF STD & AIDS, 1992, 3 (06) :414-417
[8]
HUMAN PAPILLOMAVIRUSES IN THE PATHOGENESIS OF ANOGENITAL CANCER [J].
HAUSEN, HZ .
VIROLOGY, 1991, 184 (01) :9-13
[9]
ASSOCIATION OF SERUM IMMUNOGLOBULIN-G ANTIBODIES AGAINST HUMAN PAPILLOMAVIRUS TYPE-16 CAPSIDS WITH ANAL EPIDERMOID CARCINOMA [J].
HEINO, P ;
EKLUND, C ;
FREDERIKSSONSHANAZARIAN, V ;
GOLDMAN, S ;
SCHILLER, JT ;
DILLNER, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (06) :437-440
[10]
PERSISTENCE OF TYPE-SPECIFIC HUMAN PAPILLOMAVIRUS INFECTION AMONG CYTOLOGICALLY NORMAL WOMEN [J].
HILDESHEIM, A ;
SCHIFFMAN, MH ;
GRAVITT, PE ;
GLASS, AG ;
GREER, CE ;
ZHANG, T ;
SCOTT, DR ;
RUSH, BB ;
LAWLER, P ;
SHERMAN, ME ;
KURMAN, RJ ;
MANES, MM .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :235-240